Toggle light / dark theme

An Interview with COO Dijam Panigrahi.


“a unified and shared software infrastructure to empower enterprise customers to build and run scalable, high-quality eXtended Reality (XR) – Augmented Reality (AR), Virtual Reality (VR) and Mixed Reality (MR) – applications in public, private, and hybrid clouds.”

What does that all mean?

Simply, GridRaster creates spatial, high-fidelity maps of three-dimensional physical objects. So if you plan to build an automobile or aircraft, use the software to capture an image and create a detailed mesh model overlay that can be viewed using a VR headset. The mesh model can be shared with robots and other devices.

“We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells NeuroNews, referring to the potential of brain-computer interface (BCI) technology. Alongside his role as a vascular and interventional neurologist, Oxley is chief executive officer of Synchron, developer of the Stentrode motor neuroprosthesis. The Stentrode is an implantable BCI device that, according to Oxley, is the first of its kind to be in the early feasibility clinical stage in the USA following US Food and Drug Administration (FDA) approval of Synchron’s investigational device exemption (IDE) application last month. Speaking to NeuroNewsfollowing a presentation on the topic at the Society of NeuroInterventional Surgery’s 18thannual meeting (SNIS; 26–29 July 2021, Colorado Springs, USA and virtual), Oxley gives an overview of the COMMAND early feasibility study, anticipates key results, and considers more generally how BCI technology could shape the future of deep brain stimulation.

Cosmologist, noted author, Astronomer Royal and recipient of the 2015 Nierenberg Prize for Science in the Public Interest Lord Martin Rees delivers a thought-provoking and insightful perspective on the challenges humanity faces in the future beyond 2050. [3/2016] [Show ID: 30476]

Frontiers of Knowledge.
(https://www.uctv.tv/frontiers-of-knowledge)

Explore More Science & Technology on UCTV
(https://www.uctv.tv/science)
Science and technology continue to change our lives. University of California scientists are tackling the important questions like climate change, evolution, oceanography, neuroscience and the potential of stem cells.

UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California — teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.

An experimental drug restored brain synapses in two mouse models of Alzheimer’s disease, raising hopes that it could help revive cognitive function in human dementia patients, Yale University researchers report June 1 in the journal Science Translational Medicine.

While much research in Alzheimer’s has centered on reducing levels of beta-amyloid plaque in the brain that is a hallmark of the , recent studies have suggested that immune system response in the brain also plays a role in in patients.

Some scientists now believe that cognitive decline in Alzheimer’s patients results from a loss of synaptic connections between neurons caused by a steady accumulation of beta-amyloid protein in the brain which in turn unleashes a chronic immune system response to the intruder. The end stages of the disease lead to the death of neurons.